1)Vivier E, Artis D, Colonna M, et al:Innate Lymphoid Cells: 10 Years On. Cell 174:1054-1066,2018
2)Meininger I, Carrasco A, Rao A, et al:Tissue-Specific Features of Innate Lymphoid Cells. Trends Immunol 41:902-917,2020
3)Yudanin NA, Schmitz F, Flamar AL, et al:Spatial and Temporal Mapping of Human Innate Lymphoid Cells Reveals Elements of Tissue Specificity. Immunity 50:505-519. e4,2019
4)Abel AM, Yang C, Thakar MS, et al:Natural Killer Cells: Development, Maturation, and Clinical Utilization. Front Immunol 9:1869,2018
5)Ebihara T, Jonsson AH, Yokoyama WM:Natural killer cell licensing in mice with inducible expression of MHC class I. Proc Natl Acad Sci U S A 110:E4232-E4237,2013
6)Cooper MA, Fehniger TA, Caligiuri MA:The biology of human natural killer-cell subsets. Trends Immunol 22:633-640,2001
7)Mirjačić Martinović K, Babović N, Džodić R, et al:Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients. J Transl Med 13:120,2015
8)Ebihara T, Shingai M, Matsumoto M, et al:Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Hepatology 48:48-58,2008
9)Kandarian F, Sunga GM, Arango-Saenz D, et al:A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity. J Vis Exp 2017:56191,2017
10)Mace EM, Orange JS:Emerging insights into human health and NK cell biology from the study of NK cell deficiencies. Immunol Rev 287:202-225,2019
11)Björkström NK, Strunz B, Ljunggren HG:Natural killer cells in antiviral immunity. Nat Rev Immunol, 2021, in press
12)Melaiu O, Lucarini V, Cifaldi L, et al:Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors. Front Immunol 10:3038,2020
13)Liu M, Liang S, Zhang C:NK Cells in Autoimmune Diseases: Protective or Pathogenic?. Front Immunol 12:624687,2021